Beneficient
BENF Nasdaq Finance Services Financials FY2021โFY2026
Last close ยท Oct 23, 2026
$0.80
6.5%What Beneficient does
No business description yet.
- Legal name
- Beneficient
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 10-K ยท Jun 30, 2026
- Accession ยท CIK
- 0001775734-26-000018
0001775734
Revenue and margins
Beneficient had โ$39.1M of revenue in fiscal 2026.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ$38.8M in fiscal 2026, 99.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Beneficient returned โ to shareholders in fiscal 2026. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Beneficient can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $20.3M | $8.7M | $7.9M | $1.3M | $2.5M |
| Interest coverage | โ2.6x | โ | โ150.8x | โ | โ |
| Total assets | โ | $2.9B | $369M | $355M | $239M |
| Total liabilities | โ | $232M | $310M | $299M | $338M |
| Shareholders' equity | $1.1B | $1.7B | โ$192M | โ$34.9M | โ$189M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY21 | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 4 | โ / 3 | โ / 5 | โ / 5 |
| Accruals ratio | โ | โ | โ124.3% | 24.6% | โ16.4% |
| Altman Z'' | โ | โ | โ | โ | โ |
6 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $140M | $55.3M | โ | โ$98.7M | โ$7.9M | โ$39.1M |
| Operating income | โ$47.4M | โ$71.1M | โ | โ$2.6B | โ$24.2M | โ$167M |
| Interest expense | $32.6M | $27.5M | โ | $17.6M | โ | โ |
| Pretax income | โ$47.4M | โ$105M | โ | โ$2.7B | โ$0.7M | โ$165M |
| Income tax | $3.5M | $0.0M | โ | $0.8M | $0.1M | $0.2M |
| Net income | โ$58.0M | โ$63.0M | โ | โ$2.1B | $51.2M | โ$87.4M |
| Net income to common | โ$58.0M | โ$95.0M | โ | โ$2.1B | $51.2M | โ$18.3M |
| Diluted EPS | โ$1.27 | โ$1.84 | โ | โ | โ | โ |
| Diluted shares | 0.05B | 0.05B | โ | โ | โ | โ |
| Cash flow | ||||||
| Cash from operations | โ$54.0M | โ$57.0M | โ | โ$58.2M | โ$37.7M | โ$38.7M |
| Capital expenditure | $3.2M | $4.2M | โ | $1.8M | $1.1M | $0.1M |
| Free cash flow | โ$57.2M | โ$61.2M | โ | โ$60.0M | โ$38.8M | โ$38.8M |
| Depreciation and amortization | $1.1M | $2.0M | โ | $3.8M | $1.7M | $0.7M |
| Stock-based compensation | $108M | $23.2M | โ | $39.1M | $5.6M | $1.6M |
| Balance sheet | ||||||
| Cash and short-term investments | $17.9M | $20.3M | $8.7M | $7.9M | $1.3M | $2.5M |
| Property and equipment, net | โ | โ | $4.3M | $2.3M | $1.7M | $1.1M |
| Goodwill | $2.4B | $2.4B | $2.4B | $13.6M | $9.9M | $9.9M |
| Intangible assets | โ | โ | $3.1M | $3.1M | โ | โ |
| Total assets | โ | โ | $2.9B | $369M | $355M | $239M |
| Total liabilities | โ | โ | $232M | $310M | $299M | $338M |
| Preferred stock | โ | โ | $0.0M | โ | โ | โ |
| Shareholders' equity | $986M | $1.1B | $1.7B | โ$192M | โ$34.9M | โ$189M |
| Margins | ||||||
| Operating margin | โ33.8% | โ128.6% | โ | 2,683.5% | 304.5% | 425.6% |
| EBITDA margin | โ33.0% | โ125.0% | โ | 2,679.7% | 283.1% | 423.7% |
| Net margin | โ41.4% | โ113.9% | โ | 2,123.3% | โ644.1% | 223.5% |
| FCF margin | โ40.8% | โ110.7% | โ | 60.8% | 488.5% | 99.2% |
| Returns | ||||||
| Return on equity | โ5.9% | โ6.1% | โ | โ272.8% | โ | โ |
| Return on assets | โ | โ | โ | โ127.8% | 14.1% | โ29.5% |
| Growth | ||||||
| Revenue growth | โ | โ60.6% | โ | โ | โ | โ |
| Net income growth | โ | โ | โ | โ | โ | โ270.9% |
| Share count change | โ | 12.5% | โ | โ | โ | โ |
| Financial health | ||||||
| Interest coverage | โ1.5x | โ2.6x | โ | โ150.8x | โ | โ |
| Capital allocation | ||||||
| Capex / revenue | 2.3% | 7.6% | โ | โ1.8% | โ13.8% | โ0.2% |
| Stock comp / revenue | 76.8% | 41.9% | โ | โ39.6% | โ71.1% | โ4.2% |
| Quality scores | ||||||
| Accruals ratio | โ | โ | โ | โ124.3% | 24.6% | โ16.4% |
Source: SEC EDGAR XBRL filings (CIK 0001775734). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
